W Kellogg Eye Center

Ann Arbor, Michigan 48105-1912

1 studies enrolling now · 5 studies all time

What they study most

Fuchs Endothelial Corneal Dystrophy, Fuchs' Endothelial Corneal Dystrophy, Thyroid Eye Disease, Uveal Melanoma

Studies at this site

• Neoadjuvant Darovasertib in Primary Uveal Melanoma — Recruiting now
• A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) — Completed
• A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) — Completed
• Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis — Completed